Skip to content

Clinical trials

Phase 3 Heart Failure trials in Mexico

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Heart Failure Phase: Phase 3 Country / region: Mexico Clear all

30 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20062
20071
20131
20144
20175
20182
20191
20201
20231
20243
20254
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed16
Recruiting10
Terminated3
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Boehringer Ingelheim4
AstraZeneca3
Bayer3
Novartis Pharmaceuticals3
Amgen2
Janssen Research & Development, LLC2
Novo Nordisk A/S2
Bristol-Myers Squibb1
CSL Behring1
Colorado Prevention Center1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Heart Failure30
Cardiovascular Diseases3
Coronary Artery Disease3
Stroke3
Hypertension2
Obesity2
Renal Insufficiency, Chronic2
Ventricular Dysfunction, Left2
Acute Coronary Syndrome1
Anemia1

Trials

Showing 1 to 25 of 30. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.